Recurrent Metastatic Nasopharyngeal Carcinoma

1

Review clinical trials related to Recurrent Metastatic Nasopharyngeal Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment

This is a randomized, open-label, positive-controlled, multicenter Phase Ш study to evaluate the efficacy and safety of mitoxantrone hydrochloride liposome injection combined with capecitabine versus capecitabine monotherapy in patients with recurrent metastatic nasopharyngeal carcinoma.

Participants needed: 500
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Updated: Feb 8, 2023
Eligibility criteria

Willing to participate in the study and sign the informed consent form (ICF). [+9]

Severe allergy to mitoxantrone or liposome; Previous severe, unexpected reaction... [+15]